"The US Food and Drug Administration (FDA) is warning that a case of definite multifocal leukoencephalopathy (PML) and a case of probable PML have been reported in patients taking fingolimod (Gilenya, Novartis) for relapsing forms of mult"...
Safety of doses higher than 0.25 mg every other day has not been adequately evaluated. The maximum amount of interferon beta-1b that can be safely administered has not been determined.
EXTAVIA (interferon beta-1b kit) is contraindicated in patients with a history of hypersensitivity to natural or recombinant interferon beta, Albumin (Human), USP, or any other component of the formulation.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/16/2009
Additional Extavia Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.